Candida dubliniensis Identification in Brazilian Yeast Stock Collection

Memorias do Instituto Oswaldo Cruz

Volumn 98, Issue 4, 2003, Pages 533-538

  Mariano, Priscilla De Laet Sant'Ana ^a   Milan, Eveline Pípolo ^b   Da Matta, Daniel Archimedes ^a   Colombo, Arnaldo Lopes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Aids; Candida dubliniensis; Candida spp; Oral candidiasis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PRIMER DNA; PYRROLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAZIL; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CONTROLLED STUDY; DRUG SENSITIVITY; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENOTYPE; NONHUMAN; ORAL BIOPSY; PATIENT; RANDOM AMPLIFIED POLYMORPHIC DNA; SCREENING TEST; SEROTYPE; TEMPERATURE; YEAST; AIDS RELATED COMPLEX; CANDIDA; CLASSIFICATION; DRUG EFFECT; GENETICS; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SEROTYPING; THRUSH;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGI;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; HUMANS; MICROBIAL SENSITIVITY TESTS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEROTYPING;

EID: 0142152234     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762003000400020     Document Type: Article

References (37)

1. Alves SH, Milan EP, Branchini ML, Nishimura K, Fukushima K, Oliveira LO, Costa JM, Colombo AL 2001. First isolation of Candida dubliniensis in Rio Grande do Sul, Brazil. Diag Microbiol Infect Dis 39: 165-168.
2. Barchiesi F, Najvar LK, Luther MF, Scalise G, Rinaldi MG, Graybill JR 1996. Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with Aids in an experimental murine candidiasis model. Antimicrob Agents Chemother 40: 1317-1320.
3. Bauer D, Müller H, Reich J, Riedel H, Ahrenkiel V, Warthoe P, Strauss M 1993. Identification of differentially expressed mRNA tests by an improved display technique (DDRT-PCR). Nucleic Acids Res 21: 4272-4280.
4. Brandt ME, Harrison LH, Pass M, Sofair NA, Huie S, Li R, Morrison CJ, Warnock DW, Hajjeh RA 2000. Candida dubliniensis fungemia: the first four cases in North America. Emery Infect Dis 6: 46-49.
5. Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. Aids 11: 557-567.
6. Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, Soll DR 1999. Identification of Candida dubliniensis based on temperature and utilization of xilose and α-methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC sistems. J Clin Microbiol 37: 3804-3808.
7. Jabra-Rizk MA, Falkler Jr. WA, Merz WG, Baqui AAMA, Kelley JI, Meiller TF 2000. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol 38: 2423-2426.
8. Kirkpatrick WR, Revankar SG, McAtee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, Sanche SE, Cantu RA, Rinaldi MG, Patterson TR 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 36: 3007-3012.
9. Kurzai O, Heinz WJ, Sullivan DJ, Coleman DC, Frosch M, Mühlschlegel FA 1999. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulaled PHR1 and PHR2 genes of C. albicans. J Clin Microbiol 37: 1587-1590.
10. Mannarelli BM, Kurtzman CP 1998. Rapid identification of Candida albicans and other human pathogenic yeasts by using short oligonucleotides in a PCR. J Clin Microbiol 36: 1634-1641.
11. Meiller TF, Jabra-Rizk MA, Baqui A, Kelley JI, Meeks VI, Merz WG, Falkler WA 1999. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 573-580.
12. Meis JFGM, Ruhnke M, Pauw BED, Odds FC, Siegert W, Verweij PE 1999. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emery Infect Dis 5: 150-153.
13. Melo ASA, Almeida LP, Colombo AL, Briones MRS 1998. Evolutionary distances and identification of Candida species in clinical isolates by Random Amplified Polymorphic DNA (RAPD). Mvcopathologia 142: 57-66.
14. Milan EP, Burattini MN, Kalllas EG, Fischman O, Costa PRO, Colombo AL 1998. Azole resistance among oral Candida species isolates from Aids patients under ketoconazole exposure. Diagn Microbiol Infect Dis 32: 211-216.
15. Milan EP, Sant'Ana PL, Melo ASA, Sullivan DJ, Coleman DC, Lewi D, Colombo AL 2001. Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and Aids patients. Diagn Microbiol Infect Dis 41: 29-35.
16. Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y 1994. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32: 1115-1118.
17. NCCLS-National Committee for Clinical Laboratory Standards 1997. Publication M27-A: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard, Wayne PA. NCCLS 17: 1-28.
18. Odds FC, Nuffel LV, Dams G 1998. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 36: 2869-2873.
19. Park S, Wong M, Marras SAE, Cross EW, Kiehn TE, Chaturvedi V, Tyagi S, Perlin DS 2000. Rapid identification of Candida dubliniensis using a species-specific molecular beacon. J Clin Microbiol 38: 2829-2836.
20. Persons D, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW 1991. Fluconazole and Candida krusei fugemia. N Engl J Med 325: 1315.
21. Pfaller MA, Messer AS, Gee S, Joly S, Pujol C, Sullivan DJ, Coleman DC, Soll DR 1999. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 37: 870-872.
22. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D 1998. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 36: 2093-2095.
23. Pires MFC, Birman EG, Costa CR, Gambale W, Paula CR 1996. Candida albicans byotipes isolated from the oral cavity of HIV-positive patients. Rev Microbiol 27: 46-51.
24. Rodriguez-Tudella JL, Martinez-Suarez JV, Dronda F, Laguna F, Chaves F, Valencia E 1995. Correlation of in vitro susceptibility test results with clinical response: a study of azole therapy in Aids patients. J Antimicrob Chemother 35: 793-804.
25. Salkin IF, Pruitt WR, Padhye AA, Sullivan D, Coleman D, Pincus DH 1998. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J Clin Microbiol 36: 1467.
26. Sano A, Vilela MM, Takahashi I, Fukushima K, Takizawa K, Silva MT, Uno J, Nishimura K, Miyaji M 2000. Isolation of Candida dubliniensis from the oral cavity of an HIV-positive child in Brazil. Nippon Ishinkin Gakkai Zasshi 41: 177-181.
27. Sant'Ana PL, Milan EP, Martinez R, Queiroz-Telles F, Ferreira MS, Alcântara AP, Carvalho MT, Colombo AL 2002. Multicenter Brazilian study of oral Candida species isolated from Aids patients. Mem Inst Oswaldo Cruz 97: 253-257.
28. Schoofs A, Odds FC, Colebunders R, Ieven M, Goossens H 1997. Use of a specialization isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Dis 16: 296-300.
29. Schorling SR, Kortinga HC, Froschb M, Mühlschlegel FA 2000. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals. Crit Rev Microbiol 26: 59-68.
30. St-Germain G, Dion C, Espinel-Ingroff A, Ratelle J, Repentigny L 1995. Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV. J Antimicrob Chemother 36: 109-118.
31. Sullivan D, Coleman D 1998. Candida dubliniensis: characteristics and identification. J Clin Microbiol 36: 329-334.
32. Sullivan DJ, Haynes K, Bille J, Boerlin P, Rodero L, Lloyd S, Henman M, Coleman D 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 35: 960-964.
33. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC 1995. Candida dubliniensis sp. nov. phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV infected individuals. Microbiology 141: 1507-1521.
34. Sullivan DJ, Moran G, Donnelly S, Gee S, Pinjon E, McCartan B, Shanley DB, Coleman DC 1999. Candida dubliniensis: an update. Rev Iberoam Micol 16: 72-76.
35. Tintelnot K, Haase G, Seibold M, Bergmann F, StaemmLer M, Franz T, Naumann D 2000. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 38: 1599-1608.
36. Wach A, Pich H, Phillipsen P 1994. Procedures of isolating yeast DNA for different purposes. In JR Johnston, Molecular Genetics of Yeast, Oxford University Press, Oxford, p. 10-11.
37. Willis AM, Coulter WA, Sullivan DJ, Coleman DC, Hayes JR, Bell PM, Lamey PJ 2000. Isolation of Candida dubliniensis from insulin-using diabetes mellitus patients. J Oral Pathol Med 29: 86-90.